NEW YORK, Dec. 1 (GenomeWeb News) - Shares in Epoch Biosciences were up 9.7 percent at $2.37 in mid-afternoon trading, buoyed by a recent patent announcement by corporate suitor Nanogen.


To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

The Economist writes that an increasing number of scientific journals don't do peer review.

In Science this week: genetic overlap among many psychiatric disorders, and more.